ArticleCell stem cell2025

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease.

Jeha Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.